Related Experiment Video
Updated: Jun 18, 2026

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder
Published on: April 26, 2024
Comorbidity of insomnia and depression
1Sleep Laboratory, Forenap, Centre Hospitalier de Rouffach, 27 rue du 4ème R.S.M. F-68250 Rouffach, France. luc.staner@forenap.com
Insomnia is increasingly recognized as a distinct condition, not just a depression symptom, often occurring together. Research suggests shared causes and highlights arousal as a key factor in both insomnia and depression.
Area of Science:
- Neuroscience
- Psychiatry
- Sleep Medicine
Background:
- Recent research elevates insomnia from a depression symptom to a distinct medical condition.
- High comorbidity between insomnia and depression suggests shared underlying mechanisms.
- Epidemiological data indicates potential causal links or common etiologies for both disorders.
Purpose of the Study:
- To explore the independent nature of insomnia and its relationship with depression.
- To investigate the neurobiological underpinnings, including arousal and REM sleep, common to both conditions.
- To review treatment strategies for comorbid insomnia and depression.
Main Methods:
- Review of epidemiological, neurobiological, and sleep electroencephalogram (EEG) studies.
- Analysis of the role of heightened arousal in both insomnia and depression.
- Examination of REM sleep disinhibition in individuals predisposed to depression.
Main Results:
- Insomnia may precede or co-occur with depression, suggesting shared causal factors.
- Heightened arousal is implicated as a common neurobiological factor.
- REM sleep abnormalities may indicate a predisposition to depression.
Conclusions:
- Insomnia is a significant condition with high comorbidity with depression.
- Shared neurobiological factors, particularly arousal, are crucial.
- Treatment may involve behavioral sleep management and pharmacotherapy, including antidepressants and hypnotics.
More Related Videos
04:34Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
05:34Auricular Acupuncture as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Sleep Disorders
Published on: August 18, 2023
Related Concept Videos
Insomnia
Multiple factors contribute...
Management of Insomnia
CNS Depressants: Barbiturates and Benzodiazepines
Depression: Overview
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...